QUIZARTINIB

QUIZARTINIB was reported 702 times

QUIZARTINIB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 FMS-LIKE TYROSINE KINASE 3 POSITIVE 1 0.2000
1 ADENOVIRAL ENCEPHALITIS 1 0.0909
2 FLT3 GENE MUTATION 1 0.0667
3 ORBITAL SPACE OCCUPYING LESION 1 0.0625
4 TATTOO ASSOCIATED SKIN REACTION 1 0.0435
5 MENINGOMYELITIS HERPES 1 0.0312
6 VENIPUNCTURE 1 0.0233
7 ELECTROCARDIOGRAM 1 0.0164
8 PHLEBOTOMY 1 0.0132
9 ADMINISTRATION SITE WARMTH 1 0.0122
10 HEPATIC CYST INFECTION 1 0.0102
11 VITH NERVE DISORDER 1 0.0099
12 ADENOVIRAL HAEMORRHAGIC CYSTITIS 2 0.0096
13 VESSEL PUNCTURE SITE PAIN 1 0.0094
14 DISSEMINATED TOXOPLASMOSIS 1 0.0083
15 ACUTE MYELOID LEUKAEMIA RECURRENT 17 0.0079
16 ALLOGENIC STEM CELL TRANSPLANTATION 1 0.0063
17 CATHETER SITE WARMTH 1 0.0061
18 ELECTROCARDIOGRAM QT INTERVAL ABNORMAL 3 0.0060
19 ACUTE MYELOID LEUKAEMIA REFRACTORY 1 0.0058
20 DRUG RESISTANCE MUTATION 1 0.0056
21 ACUTE MONOCYTIC LEUKAEMIA 1 0.0055
22 MENINGOCOCCAL SEPSIS 1 0.0053
23 MYOPERICARDITIS 4 0.0051
24 RADIATION ASSOCIATED PAIN 1 0.0048
25 TRANSPLANTATION COMPLICATION 2 0.0048
26 CYTOMEGALOVIRUS GASTROENTERITIS 1 0.0046
27 GASTRITIS BACTERIAL 2 0.0043
28 ABSENCE OF IMMEDIATE TREATMENT RESPONSE 1 0.0042
29 PERIPHERAL ARTERY STENOSIS 2 0.0042
30 DIFFERENTIATION SYNDROME 3 0.0041
31 ANORECTAL INFECTION 1 0.0040
32 HUMAN HERPESVIRUS 6 ENCEPHALITIS 1 0.0035
33 ENGRAFT FAILURE 1 0.0035
34 EAR INFLAMMATION 1 0.0035
35 ENTEROBACTER BACTERAEMIA 1 0.0033
36 ASPERGILLUS TEST POSITIVE 1 0.0032
37 INCREASED DOSE ADMINISTERED 1 0.0032
38 BLAST CELL COUNT INCREASED 3 0.0029
39 GRAFT VERSUS HOST DISEASE IN SKIN 6 0.0027
40 BONE MARROW DISORDER 8 0.0026
41 BONE MARROW TRANSPLANT 5 0.0026
42 CENTRAL NERVOUS SYSTEM LEUKAEMIA 1 0.0025
43 INFUSION 1 0.0024
44 STEM CELL TRANSPLANT 6 0.0024
45 CARDITIS 1 0.0024
46 ARTERIAL STENOSIS 2 0.0023
47 BIOPSY BONE MARROW 1 0.0021
48 CENTRAL VENOUS CATHETER REMOVAL 1 0.0021
49 ECZEMA ASTEATOTIC 1 0.0021
50 DISSEMINATED ASPERGILLOSIS 1 0.0021
51 NEUTROPENIC INFECTION 2 0.0021
52 MINIMAL RESIDUAL DISEASE 1 0.0021
53 MYELOID LEUKAEMIA 1 0.0020
54 SYSTOLIC DYSFUNCTION 2 0.0019
55 SEROSITIS 1 0.0018
56 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 4 0.0017
57 ENGRAFTMENT SYNDROME 1 0.0017
58 CHEMOTHERAPY 6 0.0016
59 PLATELET TRANSFUSION 2 0.0016
60 CARDIAC VENTRICULAR THROMBOSIS 2 0.0015
61 VULVAL DISORDER 1 0.0015
62 OESOPHAGITIS ULCERATIVE 1 0.0015
63 FUSARIUM INFECTION 1 0.0014
64 INTENSIVE CARE 2 0.0014
65 GRAFT VERSUS HOST DISEASE IN LIVER 1 0.0014
66 GRAFT VERSUS HOST DISEASE 10 0.0014
67 LABELLED DRUG-DRUG INTERACTION ISSUE 2 0.0014
68 PARONYCHIA 6 0.0014
69 CREATINE KINASE INCREASED 1 0.0013
70 EXTRADURAL ABSCESS 1 0.0013
71 TRANSPLANT 3 0.0013
72 ENTEROCOCCAL SEPSIS 1 0.0012
73 DENTAL DISCOMFORT 1 0.0012
74 PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL 1 0.0012
75 LEUKAEMIA RECURRENT 2 0.0012
76 THERAPY CHANGE 11 0.0011
77 CEREBRAL TOXOPLASMOSIS 1 0.0011
78 CATHETER SITE SWELLING 1 0.0011
79 ACUTE MYELOID LEUKAEMIA 16 0.0010
80 ELECTROCARDIOGRAM QT PROLONGED 35 0.0010
81 RESPIRATORY TRACT IRRITATION 1 0.0010
82 STAPHYLOCOCCAL BACTERAEMIA 4 0.0009
83 STREPTOCOCCAL BACTERAEMIA 1 0.0009
84 BRONCHOPULMONARY ASPERGILLOSIS 7 0.0009
85 KLEBSIELLA SEPSIS 1 0.0009
86 SYSTEMIC MYCOSIS 1 0.0009
87 ESCHERICHIA BACTERAEMIA 2 0.0008
88 FULL BLOOD COUNT DECREASED 17 0.0008
89 TRANSPLANT FAILURE 2 0.0008
90 PNEUMONIA FUNGAL 3 0.0008
91 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 2 0.0007
92 INVESTIGATION ABNORMAL 1 0.0007
93 CARDIAC FIBRILLATION 1 0.0007
94 CENTRAL VENOUS CATHETERISATION 2 0.0007
95 LEUKAEMIA 6 0.0006
96 WHITE BLOOD CELL COUNT ABNORMAL 4 0.0006
97 HAEMOGLOBIN ABNORMAL 4 0.0006
98 GLYCOSYLATED HAEMOGLOBIN DECREASED 1 0.0006
99 ACUTE LEUKAEMIA 1 0.0006
100 SHOULDER FRACTURE 1 0.0006
101 IGA NEPHROPATHY 1 0.0006
102 FEBRILE NEUTROPENIA 39 0.0006
103 TREATMENT DELAYED 1 0.0006
104 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 1 0.0006
105 SKIN HYPOPIGMENTATION 1 0.0006
106 NEUTROPENIC SEPSIS 4 0.0006
107 MYELOSUPPRESSION 20 0.0006
108 VULVOVAGINAL SWELLING 1 0.0005
109 SOFT TISSUE INFECTION 1 0.0005
110 CONTRAST MEDIA ALLERGY 1 0.0005
111 CEREBROSPINAL FLUID LEAKAGE 1 0.0005
112 NECROSIS 3 0.0005
113 ANGIOPATHY 3 0.0005
114 INTERVERTEBRAL DISCITIS 1 0.0005
115 HUMAN HERPESVIRUS 6 INFECTION 1 0.0005
116 ORAL INFECTION 2 0.0005
117 HYPOGEUSIA 1 0.0005
118 PLATELET COUNT ABNORMAL 3 0.0005
119 CYTOPENIA 6 0.0005
120 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 2 0.0005
121 CAPILLARY LEAK SYNDROME 1 0.0005
122 LUNG ABSCESS 1 0.0005
123 FULL BLOOD COUNT ABNORMAL 5 0.0005
124 PLATELET COUNT DECREASED 49 0.0005
125 LABORATORY TEST ABNORMAL 13 0.0004
126 METHAEMOGLOBINAEMIA 1 0.0004
127 UTERINE DISORDER 1 0.0004
128 BACTERAEMIA 5 0.0004
129 LONG QT SYNDROME 1 0.0004
130 HAEMATOLOGICAL INFECTION 1 0.0004
131 CORONARY ARTERY STENOSIS 2 0.0004
132 VASODILATATION 1 0.0004
133 PLATELET DISORDER 1 0.0004
134 NO ADVERSE EVENT 71 0.0004
135 PRODUCT PACKAGING DIFFICULT TO OPEN 1 0.0004
136 ELECTROCARDIOGRAM ABNORMAL 3 0.0004
137 LUNG OPACITY 1 0.0004
138 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 1 0.0004
139 BLOOD POTASSIUM ABNORMAL 1 0.0004
140 CHOLECYSTITIS INFECTIVE 1 0.0004
141 ENDOTRACHEAL INTUBATION 1 0.0004
142 ENTEROCOLITIS 2 0.0003
143 ADENOVIRUS INFECTION 1 0.0003
144 ADRENAL INSUFFICIENCY 4 0.0003
145 BLOOD CREATININE DECREASED 1 0.0003
146 PNEUMONIA VIRAL 1 0.0003
147 BACTERIAL SEPSIS 1 0.0003
148 PLANTAR FASCIITIS 1 0.0003
149 DISEASE PROGRESSION 35 0.0003
150 CLOSTRIDIAL INFECTION 1 0.0003
151 NEOPLASM RECURRENCE 1 0.0003
152 NEUTROPHIL COUNT DECREASED 12 0.0003
153 APLASIA PURE RED CELL 1 0.0003
154 LOCALISED INFECTION 7 0.0003
155 HYPOPNOEA 1 0.0003
156 BLOOD TEST ABNORMAL 4 0.0003
157 PRODUCT SUPPLY ISSUE 2 0.0003
158 AMYLASE INCREASED 1 0.0003
159 CARDIOMYOPATHY 4 0.0003
160 GASTRIC INFECTION 1 0.0003
161 PERICARDIAL EFFUSION 6 0.0003
162 TASTE DISORDER 5 0.0002
163 INFECTION 35 0.0002
164 CONGESTIVE CARDIOMYOPATHY 1 0.0002
165 WHITE BLOOD CELL COUNT DECREASED 25 0.0002
166 SEPTIC SHOCK 10 0.0002
167 CARDIOTOXICITY 2 0.0002
168 ORAL PAIN 5 0.0002
169 VASCULAR DEVICE INFECTION 1 0.0002
170 SKIN LESION 6 0.0002
171 DISEASE COMPLICATION 1 0.0002
172 EAR DISORDER 1 0.0002
173 IMMUNE THROMBOCYTOPENIA 1 0.0002
174 PANCYTOPENIA 12 0.0002
175 SKIN ABRASION 1 0.0002
176 HAEMATOTOXICITY 2 0.0002
177 CARDIAC TAMPONADE 1 0.0002
178 RED BLOOD CELL COUNT DECREASED 6 0.0002
179 HYPOVOLAEMIC SHOCK 1 0.0002
180 ENTEROCOCCAL INFECTION 1 0.0002
181 SINUS BRADYCARDIA 2 0.0002
182 LIVER DISORDER 9 0.0002
183 VENOOCCLUSIVE LIVER DISEASE 1 0.0002
184 ORGANISING PNEUMONIA 1 0.0002
185 VEIN DISORDER 1 0.0002
186 PERIPHERAL VASCULAR DISORDER 1 0.0002
187 PERIORBITAL OEDEMA 1 0.0002
188 VENTRICULAR EXTRASYSTOLES 2 0.0002
189 TRANSFUSION 2 0.0002
190 BLOOD LACTATE DEHYDROGENASE INCREASED 3 0.0002
191 HEPATIC FUNCTION ABNORMAL 7 0.0002
192 COMPRESSION FRACTURE 1 0.0002
193 ANAL ABSCESS 1 0.0002
194 STRESS FRACTURE 1 0.0002
195 PRODUCT PRESCRIBING ISSUE 4 0.0002
196 ASTHENOPIA 1 0.0002
197 PULMONARY ALVEOLAR HAEMORRHAGE 1 0.0002
198 PERIORBITAL SWELLING 1 0.0002
199 MOUTH SWELLING 1 0.0002
200 BLOOD URIC ACID INCREASED 1 0.0002
201 GANGRENE 1 0.0002
202 PHOTOPSIA 1 0.0002
203 HAEMOGLOBIN DECREASED 16 0.0002
204 REFUSAL OF TREATMENT BY PATIENT 1 0.0002
205 TOOTH INFECTION 2 0.0002
206 VIRAL INFECTION 5 0.0002
207 CARDIAC FAILURE ACUTE 1 0.0001
208 TERMINAL STATE 1 0.0001
209 BODY TEMPERATURE INCREASED 3 0.0001
210 DISSEMINATED INTRAVASCULAR COAGULATION 2 0.0001
211 PULMONARY TOXICITY 1 0.0001
212 TONGUE DISORDER 1 0.0001
213 MOUTH HAEMORRHAGE 1 0.0001
214 INSURANCE ISSUE 2 0.0001
215 LIPASE INCREASED 1 0.0001
216 DEVICE RELATED INFECTION 2 0.0001
217 HAEMOLYSIS 1 0.0001
218 PULMONARY HAEMORRHAGE 1 0.0001
219 BRAIN FOG 2 0.0001
220 ILLNESS 13 0.0001
221 THERAPY INTERRUPTED 9 0.0001
222 PYREXIA 43 0.0001
223 FRUSTRATION TOLERANCE DECREASED 1 0.0001
224 OSTEONECROSIS 4 0.0001
225 CYTOMEGALOVIRUS INFECTION 2 0.0001
226 PRODUCT CONTAINER ISSUE 1 0.0001
227 PSEUDOMONAS INFECTION 1 0.0001
228 BLOOD MAGNESIUM DECREASED 1 0.0001
229 MUSCLE STRAIN 1 0.0001
230 ILL-DEFINED DISORDER 7 0.0001
231 RESPIRATORY SYNCYTIAL VIRUS INFECTION 1 0.0001
232 NEUROTOXICITY 2 0.0001
233 IMMUNOSUPPRESSION 1 0.0001
234 PRODUCT COMMUNICATION ISSUE 1 0.0001
235 PURPURA 1 0.0001
236 GASTROINTESTINAL INFECTION 1 0.0001
237 OROPHARYNGEAL DISCOMFORT 1 0.0001
238 LIP DRY 1 0.0001
239 HYPERGLYCAEMIA 4 0.0001
240 PNEUMONIA BACTERIAL 1 0.0001
241 PRODUCT DOSE OMISSION ISSUE 32 0.0001
242 PRODUCT DISTRIBUTION ISSUE 1 0.0001
243 BACTERIAL INFECTION 2 0.0001
244 MULTIPLE ORGAN DYSFUNCTION SYNDROME 3 0.0001
245 BLOOD CREATINE PHOSPHOKINASE INCREASED 3 0.0001
246 POST PROCEDURAL COMPLICATION 2 0.0001
247 ATELECTASIS 1 0.0001
248 THROMBOTIC MICROANGIOPATHY 1 0.0001
249 AUTOIMMUNE DISORDER 1 0.0001
250 DECREASED IMMUNE RESPONSIVENESS 1 0.0001
251 BRAIN INJURY 1 0.0001
252 PNEUMOCYSTIS JIROVECII PNEUMONIA 1 0.0001
253 PLEURAL EFFUSION 6 0.0001
254 DRUG LEVEL DECREASED 1 0.0001
255 SUBARACHNOID HAEMORRHAGE 1 0.0001
256 SLUGGISHNESS 1 0.0001
257 EMOTIONAL DISORDER 3 0.0001
258 HYPERBILIRUBINAEMIA 1 0.0001
259 PRODUCT USE ISSUE 18 0.0001
260 MOUTH ULCERATION 2 0.0001
261 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
262 UNEVALUABLE EVENT 7 0.0001
263 SKIN LACERATION 1 0.0001
264 WOUND INFECTION 1 0.0001
265 STAPHYLOCOCCAL INFECTION 3 0.0001
266 OFF LABEL USE 79 0.0001
267 VENTRICULAR FIBRILLATION 1 0.0001
268 FUNGAL INFECTION 3 0.0001
269 PNEUMONIA 29 0.0001
270 SKIN INFECTION 1 0.0001
271 OCULAR DISCOMFORT 1 0.0001
272 NEUTROPENIA 12 0.0001
273 MYOCARDITIS 1 0.0001
274 TINNITUS 4 0.0001
275 GASTRIC HAEMORRHAGE 1 0.0001
276 METASTASES TO LUNG 1 0.0001
277 ELECTROLYTE IMBALANCE 1 0.0001
278 COVID-19 PNEUMONIA 1 0.0001
279 TENDON RUPTURE 1 0.0001
280 GENERALISED OEDEMA 1 0.0001
281 ILEUS 1 0.0001
282 PNEUMONIA ASPIRATION 2 0.0001
283 ROTATOR CUFF SYNDROME 1 0.0001
284 MUCOSAL INFLAMMATION 2 0.0001
285 IMMUNE SYSTEM DISORDER 1 0.0001
286 DYSMENORRHOEA 1 0.0001
287 BLOOD BILIRUBIN INCREASED 2 0.0001
288 HEPATIC ENZYME INCREASED 5 0.0001
289 CENTRAL NERVOUS SYSTEM LESION 1 0.0001
290 DIVERTICULITIS 2 0.0001
291 HYPOMAGNESAEMIA 1 0.0001
292 PRODUCT DOSE OMISSION IN ERROR 2 0.0001
293 SINUS TACHYCARDIA 1 0.0001
294 GASTROENTERITIS 1 0.0001
295 PSYCHOTIC DISORDER 2 0.0001
296 ADVERSE DRUG REACTION 6 0.0001
297 CORONARY ARTERY DISEASE 2 0.0001
298 HIP ARTHROPLASTY 1 0.0001
299 DEATH 56 0.0001
300 ANKLE FRACTURE 1 0.0001
301 DRUG-INDUCED LIVER INJURY 2 0.0001
302 PRODUCT USE COMPLAINT 1 0.0001
303 NAUSEA 50 0.0001
304 DISEASE RECURRENCE 3 0.0001
305 DRUG INTERACTION 10 0.0001
306 LUNG DISORDER 3 0.0001
307 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1 0.0001
308 ORTHOSTATIC HYPOTENSION 1 0.0001
309 HYPOXIA 2 0.0001
310 DEPRESSED MOOD 3 0.0001
311 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
312 GALLBLADDER DISORDER 1 0.0001
313 CEREBRAL HAEMORRHAGE 2 0.0001
314 GASTROINTESTINAL DISORDER 5 0.0001
315 OSTEOMYELITIS 1 0.0001
316 RESTLESS LEGS SYNDROME 1 0.0001
317 BONE DISORDER 1 0.0001
318 THROMBOCYTOPENIA 6 0.0001
319 EPISTAXIS 4 0.0001
320 TUBULOINTERSTITIAL NEPHRITIS 1 0.0001
321 COLITIS 2 0.0001
322 DYSPHAGIA 5 0.0001
323 NEUROPATHY PERIPHERAL 5 0.0001
324 MUSCULOSKELETAL DISORDER 1 0.0001
325 INCREASED APPETITE 1 0.0001
326 WHITE BLOOD CELL COUNT INCREASED 2 0.0001
327 ACUTE RESPIRATORY FAILURE 1 0.0001
328 HERNIA 1 0.0001
329 PRESCRIBED OVERDOSE 1 0.0001
330 COVID-19 9 0.0001
331 ORAL HERPES 1 0.0001
332 KIDNEY INFECTION 1 0.0001
333 ASTHENIA 19 0.0001
334 SINUS DISORDER 1 0.0001
335 UPPER LIMB FRACTURE 1 0.0001
336 THERAPEUTIC RESPONSE DECREASED 3 0.0000
337 PRODUCT ADMINISTRATION ERROR 1 0.0000
338 STOMATITIS 3 0.0000
339 FEEDING DISORDER 1 0.0000
340 ROAD TRAFFIC ACCIDENT 2 0.0000
341 DERMATITIS 1 0.0000
342 ABDOMINAL DISCOMFORT 8 0.0000
343 FATIGUE 37 0.0000
344 RETCHING 1 0.0000
345 IRRITABLE BOWEL SYNDROME 1 0.0000
346 LIVER FUNCTION TEST INCREASED 1 0.0000
347 POOR QUALITY SLEEP 1 0.0000
348 FAECES DISCOLOURED 1 0.0000
349 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
350 TRANSAMINASES INCREASED 1 0.0000
351 SEPSIS 5 0.0000
352 VOMITING 21 0.0000
353 SHOCK 1 0.0000
354 HYPOKALAEMIA 2 0.0000
355 UPPER RESPIRATORY TRACT INFECTION 2 0.0000
356 OROPHARYNGEAL PAIN 4 0.0000
357 RENAL DISORDER 2 0.0000
358 OCULAR HYPERAEMIA 2 0.0000
359 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2 0.0000
360 INTERSTITIAL LUNG DISEASE 2 0.0000
361 PRESYNCOPE 1 0.0000
362 CEREBRAL INFARCTION 1 0.0000
363 DYSPEPSIA 4 0.0000
364 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
365 AGEUSIA 1 0.0000
366 DRY EYE 2 0.0000
367 HAEMATEMESIS 1 0.0000
368 CHEST DISCOMFORT 4 0.0000
369 UNRESPONSIVE TO STIMULI 1 0.0000
370 DIARRHOEA 25 0.0000
371 PANCREATITIS 2 0.0000
372 CARDIAC FAILURE 3 0.0000
373 DRY MOUTH 3 0.0000
374 CONSTIPATION 8 0.0000
375 RESPIRATORY ARREST 1 0.0000
376 MENTAL STATUS CHANGES 1 0.0000
377 WOUND 1 0.0000
378 RENAL IMPAIRMENT 3 0.0000
379 PAIN IN JAW 1 0.0000
380 INTENTIONAL DOSE OMISSION 1 0.0000
381 ANGINA PECTORIS 1 0.0000
382 HYPERSOMNIA 1 0.0000
383 EYE IRRITATION 2 0.0000
384 BALANCE DISORDER 3 0.0000
385 DECREASED APPETITE 8 0.0000
386 RASH 15 0.0000
387 ASCITES 1 0.0000
388 RESPIRATORY DISORDER 1 0.0000
389 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 6 0.0000
390 APHASIA 1 0.0000
391 LACRIMATION INCREASED 1 0.0000
392 EMOTIONAL DISTRESS 4 0.0000
393 HOSPITALISATION 5 0.0000
394 CARDIAC DISORDER 3 0.0000
395 NERVOUS SYSTEM DISORDER 1 0.0000
396 ANAEMIA 6 0.0000
397 HIP FRACTURE 1 0.0000
398 NIGHT SWEATS 1 0.0000
399 BLOOD CREATININE INCREASED 2 0.0000
400 ALOPECIA 6 0.0000
401 EYE DISORDER 1 0.0000
402 HEART RATE INCREASED 3 0.0000
403 INSOMNIA 8 0.0000
404 VISION BLURRED 4 0.0000
405 BURNING SENSATION 2 0.0000
406 HEART RATE DECREASED 1 0.0000
407 MOBILITY DECREASED 2 0.0000
408 DRUG EFFECT INCOMPLETE 1 0.0000
409 RESTLESSNESS 1 0.0000
410 AGITATION 2 0.0000
411 NASOPHARYNGITIS 5 0.0000
412 BRONCHITIS 2 0.0000
413 INTESTINAL OBSTRUCTION 1 0.0000
414 THROMBOSIS 2 0.0000
415 CARDIAC ARREST 2 0.0000
416 POLLAKIURIA 1 0.0000
417 GASTROINTESTINAL HAEMORRHAGE 2 0.0000
418 HYPERTENSION 5 0.0000
419 OSTEOARTHRITIS 1 0.0000
420 MYALGIA 4 0.0000
421 LOSS OF CONSCIOUSNESS 3 0.0000
422 HYPOACUSIS 1 0.0000
423 INTENTIONAL PRODUCT MISUSE 2 0.0000
424 INTENTIONAL PRODUCT USE ISSUE 2 0.0000
425 TACHYCARDIA 2 0.0000
426 THERAPEUTIC RESPONSE UNEXPECTED 1 0.0000
427 THERAPY NON-RESPONDER 1 0.0000
428 DIZZINESS 11 0.0000
429 INCORRECT DOSE ADMINISTERED 5 0.0000
430 SKIN DISCOLOURATION 1 0.0000
431 ADVERSE EVENT 2 0.0000
432 CHEST PAIN 4 0.0000
433 ANXIETY 6 0.0000
434 PRODUCTIVE COUGH 1 0.0000
435 DRUG INTOLERANCE 2 0.0000
436 HYPOAESTHESIA 3 0.0000
437 SYNCOPE 2 0.0000
438 SOMNOLENCE 4 0.0000
439 CELLULITIS 1 0.0000
440 SINUSITIS 2 0.0000
441 THERAPY CESSATION 1 0.0000
442 PERIPHERAL SWELLING 3 0.0000
443 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
444 ABDOMINAL DISTENSION 2 0.0000
445 HEADACHE 12 0.0000
446 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
447 RASH PRURITIC 1 0.0000
448 OEDEMA 1 0.0000
449 ARTHROPATHY 1 0.0000
450 INFLUENZA 2 0.0000
451 URTICARIA 3 0.0000
452 OXYGEN SATURATION DECREASED 1 0.0000
453 FLATULENCE 1 0.0000
454 URINARY TRACT INFECTION 3 0.0000
455 HERPES ZOSTER 1 0.0000
456 GENERAL PHYSICAL HEALTH DETERIORATION 2 0.0000
457 BACK PAIN 4 0.0000
458 PALPITATIONS 2 0.0000
459 BONE PAIN 1 0.0000
460 WHEEZING 1 0.0000
461 FEELING HOT 1 0.0000
462 GAIT DISTURBANCE 3 0.0000
463 DEEP VEIN THROMBOSIS 1 0.0000
464 SWELLING FACE 1 0.0000
465 BLOOD PRESSURE DECREASED 1 0.0000
466 DRY SKIN 2 0.0000
467 NEOPLASM MALIGNANT 1 0.0000
468 ERYTHEMA 3 0.0000
469 ABDOMINAL PAIN UPPER 3 0.0000
470 MEMORY IMPAIRMENT 2 0.0000
471 ARTHRALGIA 6 0.0000
472 COUGH 4 0.0000
473 SLEEP DISORDER 1 0.0000
474 UNDERDOSE 1 0.0000
475 PAIN IN EXTREMITY 4 0.0000
476 DYSGEUSIA 1 0.0000
477 PAIN 8 0.0000
478 ABDOMINAL PAIN 3 0.0000
479 PARAESTHESIA 2 0.0000
480 CARDIAC FAILURE CONGESTIVE 1 0.0000
481 GASTROOESOPHAGEAL REFLUX DISEASE 1 0.0000
482 DYSPNOEA 7 0.0000
483 INFLUENZA LIKE ILLNESS 1 0.0000
484 TREATMENT FAILURE 1 0.0000
485 PRODUCT STORAGE ERROR 1 0.0000
486 HYPERSENSITIVITY 2 0.0000
487 WEIGHT DECREASED 3 0.0000
488 MIGRAINE 1 0.0000
489 CONTUSION 1 0.0000
490 ATRIAL FIBRILLATION 1 0.0000
491 HYPOTENSION 2 0.0000
492 MALAISE 4 0.0000
493 DRUG INEFFECTIVE 12 0.0000
494 CHILLS 1 0.0000
495 FEELING ABNORMAL 2 0.0000
496 JOINT SWELLING 1 0.0000
497 PRODUCT USE IN UNAPPROVED INDICATION 2 0.0000
498 PRURITUS 3 0.0000
499 PRODUCT QUALITY ISSUE 1 0.0000
500 BLOOD PRESSURE INCREASED 1 0.0000
501 ACUTE KIDNEY INJURY 1 0.0000
502 FALL 2 0.0000
503 MYOCARDIAL INFARCTION 1 0.0000
504 MUSCLE SPASMS 1 0.0000
505 WEIGHT INCREASED 1 0.0000
506 DEPRESSION 1 0.0000